| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $86.1M | -26.9% |
| SG&A Expense | $49.3M | -17.8% |
| Operating Income | -$138.4M | +25.5% |
| Net Income | -$136.1M | +26.6% |
| EPS (Basic) | -$2.50 | +28.2% |
| EPS (Diluted) | -$2.50 | +28.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.6M | -73.2% |
| Current Assets | $197.0M | -39.4% |
| Total Assets | $243.5M | -31.4% |
| Current Liabilities | $18.4M | -37.8% |
| Total Liabilities | $42.2M | +15.8% |
| Stockholders' Equity | $201.4M | -36.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$118.2M | +6.8% |
| Investing Cash Flow | $25.2M | +155.0% |
| Financing Cash Flow | -$1.4M | -100.8% |